Company intelligence / Profile preview

Arkitekt Ventures

New York City, New York, United Statesarkitektventures.com ↗

Ownership: Private
Employees: ~1
Development stage: Commercial

Overview

Arkitekt Ventures is an early-stage venture capital fund focused on investing in innovative healthcare delivery models and frontier technology applications to medicine. The firm supports visionary technical founders working on challenging problems at the intersection of health and advanced technologies such as artificial intelligence, neurotechnology, AR/VR, and quantum computing. It has made at least 19–23 investments since its founding in 2017 with notable portfolio companies including Darmiyan, Shield Bio, Paradromics, BehaVR, Cake, and HumanFirst. The fund is active primarily in the United States with headquarters in New York.

Industry: Investors

Partnerships

The Chernin Group (co-investor)Trail Mix Ventures (co-investor)Amplo (co-investor)

Beyond the preview

Go deeper on Arkitekt Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arkitekt Ventures.

Explore the full profile